The groundbreaking therapy of the medication represents a significant development in the handling of type 2 diabetes. Unlike existing drugs, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and GIP https://tirzepatidepeptide043970.blogginaway.com/42804263/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment